US Biomarkers

US Biomarkers was a privately held U.S. molecular diagnostics company focused on epigenetic biomarker products and services, particularly DNA methylation-based assays for clinical diagnostics and companion diagnostics. The company appears to have concentrated on blood-based and other minimally invasive biomarker approaches for oncology and neurodegenerative diseases. Publicly available descriptions emphasize genome-wide DNA methylation analysis capabilities and proprietary biomarker discovery methods rather than a broad commercial product portfolio. Patent and profile information indicates work on early colorectal cancer detection and broader biomarker applications. Third-party startup and company databases suggest the business is no longer active.